ABC of monitoring drug therapy. Digoxin.

ABC of monitoring drug therapy. Digoxin.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Aronson, J, Hardman, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1992

Παρόμοια τεκμήρια

ABC of monitoring drug therapy. Why monitor drug therapy?
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

ABC of monitoring drug therapy. Patient compliance.
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

ABC of monitoring drug therapy. Theophylline.
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

ABC of monitoring drug therapy. Phenytoin.
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

ABC of monitoring drug therapy. Measuring plasma drug concentrations.
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
ανά: Aronson, J, κ.ά.
Έκδοση: (1978)

Monitoring digoxin therapy: III. How useful are the nomograms?
ανά: Aronson, J
Έκδοση: (1978)

ABC of monitoring drug therapy. Lithium.
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

ABC of monitoring drug therapy. Cyclosporin.
ανά: Reynolds, D, κ.ά.
Έκδοση: (1992)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
ανά: Aronson, J, κ.ά.
Έκδοση: (1977)

ABC of monitoring drug therapy. Aminoglycoside antibiotics.
ανά: Aronson, J, κ.ά.
Έκδοση: (1992)

Digoxin revisited.
ανά: Aronson, J
Έκδοση: (1998)

Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
ανά: Rony Abdi Syahputra, κ.ά.
Έκδοση: (2022-04-01)

ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.
ανά: Reynolds, D, κ.ά.
Έκδοση: (1993)

Interaction of digoxin with quinine.
ανά: Aronson, J, κ.ά.
Έκδοση: (1981)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
ανά: S. F. Zadvorev, κ.ά.
Έκδοση: (2018-05-01)

Clinical pharmacokinetics of digoxin 1980.
ανά: Aronson, J
Έκδοση: (1980)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
ανά: Aronson, J, κ.ά.
Έκδοση: (1977)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
ανά: Ford, A, κ.ά.
Έκδοση: (1979)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
ανά: Aronson, J, κ.ά.
Έκδοση: (1983)

Indications for the measurement of plasma digoxin concentrations.
ανά: Aronson, J
Έκδοση: (1983)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
ανά: M Yurdakök, κ.ά.
Έκδοση: (1989-10-01)

Appropriateness of digoxin level monitoring
ανά: MR Mordasini, κ.ά.
Έκδοση: (2002-09-01)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
ανά: Aronson, J, κ.ά.
Έκδοση: (1980)

In vivo cation transport during short-term and long-term digoxin therapy.
ανά: Boon, N, κ.ά.
Έκδοση: (1986)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
ανά: Boon, N, κ.ά.
Έκδοση: (1984)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
ανά: Ford, A, κ.ά.
Έκδοση: (1979)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
ανά: Pugh, S, κ.ά.
Έκδοση: (1982)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
ανά: Aronson, J, κ.ά.
Έκδοση: (1982)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
ανά: Sophia Sheikh, κ.ά.
Έκδοση: (2024-06-01)

Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods
ανά: Isabel Cristina Medeiros Barros, κ.ά.
Έκδοση: (2014-01-01)

Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care
ανά: Emma M García-Iranzo, κ.ά.
Έκδοση: (2017-07-01)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
ανά: Zeynep ÖZTÜRK, κ.ά.
Έκδοση: (2018-01-01)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
ανά: Antonella Colella, κ.ά.
Έκδοση: (2022-06-01)

Monitoring drug therapy.
ανά: Buclin, T, κ.ά.
Έκδοση: (2012)

Neglected facts in digoxin intoxication
ανά: Sibel Ocak Serin
Έκδοση: (2017-06-01)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
ανά: Marcin Wais, κ.ά.
Έκδοση: (2024-04-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
ανά: Tadej Petreski, κ.ά.
Έκδοση: (2023-08-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and performance of an isolated, perfused working guinea-pig heart
ανά: Zannad, F, κ.ά.
Έκδοση: (1982)

THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART
ανά: Zannad, F, κ.ά.
Έκδοση: (1982)